---
title: "TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289517290.md"
description: "TherapeuticsMD Inc. (TXMD) shares fell 2.15% to $1.82 on Thursday, underperforming the broader market and competitors like AbbVie despite a strong trading session for major indices. This marks the stock's second consecutive day of losses, with prices now 38.31% below its 52-week high. Trading volume exceeded its 50-day average."
datetime: "2026-06-11T21:32:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289517290.md)
  - [en](https://longbridge.com/en/news/289517290.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289517290.md)
---

# TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) shed 2.15% to $1.82 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 2.54% to 25,809.66 and the Dow Jones Industrial Average rising 1.86% to 50,848.75.

This was the stock's second consecutive day of losses.

TherapeuticsMD Inc. closed 38.31% below its 52-week high of $2.95, which the company achieved on January 27th.

The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 0.08% to $224.77.

Trading volume (53,712) eclipsed its 50-day average volume of 31,408.

Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-11-26 1732ET

### Related Stocks

- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/289643555.md)
- [TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors](https://longbridge.com/en/news/289380150.md)
- [Saturna Capital Corp Purchases 31,143 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/289451855.md)
- [Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?](https://longbridge.com/en/news/289009743.md)
- [AbbVie, Devon Energy And More On CNBC's 'Final Trades'](https://longbridge.com/en/news/289461383.md)